Professor Mike Dragunow is a neuropharmacologist and neuroscientist and heads a large academic laboratory at the University of Auckland. Mike developed the human brain tissue microarray, human brain cell culture and high content analysis techniques used by Neurovalida scientists. Mike also founded and directs the Human Brain Tissue Microarray and the High Content Screening facilities at the University of Auckland and directs the Hugh Green Biobank. His research focuses on studying the causes of human brain disorders and on developing novel drug treatments for these disorders using adult human brain, tissue microarray, primary adult human brain cell cultures, molecular pharmacology, high throughput devices and high-content analysis. He is a Fellow of the Royal Society of New Zealand and has had significant biotech experience as a neuroscience consultant and Scientific Advisory Board member. Mike has an H-index of 95 and has published more than 340 peer reviewed publications which have been cited over 35,000 times (Google Scholar).